国际医药卫生导报2013，Vol.19Issue(9)：1221-1223,3.DOI:10.3760/cma.j.issn.1007-1245.2013.09.002
放疗联合艾迪注射液治疗鼻咽癌疗效与预后因子的临床研究
Radiotherapy combined with AiDi for asopharynx cancer and the prognostic factor
摘要
Abstract
Objective To investigate the efficacy of AiDi for nasopharynx cancer.Methods Patients with nasopharynx cancer were randomly assigned to experiment group and control group.And the experiment group were treated with AiDi and rediochemotherapy while the control group took only radiochemotheapy.After the whole therapy,the MRI of nasopharynx,EBV-DNA,blood test,weight were tested.And the data were analyzed with SPSS 16.0 software.Results The EBV-DNA in the experiment group were obviously reduced,but there was no statistical difference in CR.Conclusions AiDi could reduce the EBV-DNA and EBV Virus titer,but it can' t improve the remission rate.关键词
艾迪注射液/鼻咽癌Key words
AiDi/Nasopharynx cancer引用本文复制引用
胡家柱,谭洁霞,何艳,李济时,黎益华,曹小龙..放疗联合艾迪注射液治疗鼻咽癌疗效与预后因子的临床研究[J].国际医药卫生导报,2013,19(9):1221-1223,3.基金项目
广东省中医药管理局2010年立项课题(2010289) （2010289）
